Simple, Efficient, and Applicable Route for Synthesis of 2-Aryl(Heteroaryl)-Benzimidazoles at Room Temperature Using Copper Nanoparticles on Activated Carbon as a Reusable Heterogeneous Catalyst
Abstract:A series of 2-(hetero)arylbenzimidazoles were synthesized by the catalytic condensation of (hetero)aryl aldehydes with 1,2-phenylenediamine derivatives at room temperature in the presence of air as the oxidant. Copper nanoparticles on charcoal was employed as an efficient and mild catalyst for this methodology.
“…Benzimidazole nucleus is considered to be a distinctive synthon for building up versatile biologically active molecules. In the last decade, many efforts were devoted for synthesis of various benzimidazole derivatives (Chen et al, 2013;Sharghi, Khalifeh, Mansouri, Aberi, & Eskandari, 2011). The most commonly used synthetic approach typically involves the condensation of o-arylenediamines with carbonyl compounds, like aldehydes, carboxylic acids, or their derivatives, which often requires strong acidic conditions, using elevated temperature or microwave irradiation (Du & Luo, 2010;Lin & Yang, 2005;Salehi, Dabiri, Zolfigol, Otokesh, & Baghbanzadeh, 2006;Tempest et al, 2001).…”
Three new series of 2‐phenyl benzimidazole‐based derivatives were designed, synthesized, and evaluated for their in vitro cytotoxic activity against breast cancer (MCF‐7) cell lines. Three compounds 8, 9, and 15 showed high cytotoxic activities, with IC50 values of 3.37, 6.30, and 5.84 μM, respectively, while they showed comparable cytotoxicity to the standard drug doxorubicin against human normal cells, including nontumorigenic breast epithelial cell line (MCF‐10F), skin fibroblast cell line (BJ), and lung fibroblast cell line (MRC‐5). Six of the synthesized compounds were screened against vascular endothelial growth factor receptor 2 (VEGFR‐2) where compounds 8, 9, 12, and 15 exhibited an outstanding potency in comparison with sorafenib, with IC50 values of 6.7–8.9 nM. Molecular docking study assessed the good binding patterns of the most potent compounds with the reported conserved amino acids of VEGFR‐2 active site.
“…Benzimidazole nucleus is considered to be a distinctive synthon for building up versatile biologically active molecules. In the last decade, many efforts were devoted for synthesis of various benzimidazole derivatives (Chen et al, 2013;Sharghi, Khalifeh, Mansouri, Aberi, & Eskandari, 2011). The most commonly used synthetic approach typically involves the condensation of o-arylenediamines with carbonyl compounds, like aldehydes, carboxylic acids, or their derivatives, which often requires strong acidic conditions, using elevated temperature or microwave irradiation (Du & Luo, 2010;Lin & Yang, 2005;Salehi, Dabiri, Zolfigol, Otokesh, & Baghbanzadeh, 2006;Tempest et al, 2001).…”
Three new series of 2‐phenyl benzimidazole‐based derivatives were designed, synthesized, and evaluated for their in vitro cytotoxic activity against breast cancer (MCF‐7) cell lines. Three compounds 8, 9, and 15 showed high cytotoxic activities, with IC50 values of 3.37, 6.30, and 5.84 μM, respectively, while they showed comparable cytotoxicity to the standard drug doxorubicin against human normal cells, including nontumorigenic breast epithelial cell line (MCF‐10F), skin fibroblast cell line (BJ), and lung fibroblast cell line (MRC‐5). Six of the synthesized compounds were screened against vascular endothelial growth factor receptor 2 (VEGFR‐2) where compounds 8, 9, 12, and 15 exhibited an outstanding potency in comparison with sorafenib, with IC50 values of 6.7–8.9 nM. Molecular docking study assessed the good binding patterns of the most potent compounds with the reported conserved amino acids of VEGFR‐2 active site.
2‐(5‐Substituted phenyl)furan‐2‐carboxaldehyde derivatives were prepared by using an efficient copper(II) complex of tetradentate Schiff‐base ligand immobilized onto silica as a heterogeneous nanocatalyst [Cu(II) Schiff‐base@SiO2] (5.0 mol%) using anilines, sodium nitrite, and furan‐2‐carboxaldehyde. Furthermore, attractive di‐heteroaryl benzo‐fused systems such as benzimidazole and benzothiazole derivatives were synthesized using this nanocatalyst (5.0 mol%) via the reaction of o‐phenylenediamines and 2‐aminothiophenol with 2‐(5‐substituted phenyl)furan‐2‐carboxaldehydes in EtOH. The catalyst was characterized by Fourier transform infrared (FT‐IR), field emission scanning electron microscope (FESEM), energy‐dispersive X‐ray spectroscopy (EDX), X‐ray powder diffraction (XRD), and inductively coupled plasma (ICP) techniques. The advantages of the present catalytic system are short reaction times, mild conditions, good to excellent yields, and low amount of nanocatalyst. Moreover, to the best of our knowledge, this is the first time of using the same catalyst in two steps including synthesis of 2‐(5‐substituted phenyl)furan‐2‐carboxaldehyde and benzimidazole or benzothiazole derivatives. In addition, the synthesized catalyst was recycled very well and reused several times without significant loss of its catalytic activity.
“…Previously, we have reported on copper nanoparticles on charcoal (Cu/C) as an excellent heterogeneous cat-alyst for the synthesis of triazole, 38 propargylamine, 39 benzimidazole, 40 2-amino-3-cyanopyridine, 41 indazole 42 and imidazole derivatives. 43 In continuation of our studies on the synthesis of heterocycles and the use of heterogeneous catalysts in organic reactions, [44][45][46][47][48][49][50][51][52][53][54][55][56] we describe here a new strategy for the preparation of tetrazole derivatives.…”
A new, efficient and convenient method for the synthesis of 5-substituted 1H-tetrazole derivatives with a wide range of substituents in good to excellent yields has been developed. The synthesis was performed by the one-pot three-component [3+2]cycloaddition reaction between aldehyde, hydroxylamine and sodium azide in the presence of Cu/C. The reaction probably proceeds by the in situ formation of nitriles followed by successive [3+2]cycloaddition with sodium azide. A variety of aldehydes were used to obtain the corresponding tetrazoles. The catalyst was recovered by simple filtration and reused at least five times without significant loss of catalytic activity. The use of this method offers additional advantages for the synthesis of 5-substituted 1H-tetrazole derivatives, including the easy availability of starting materials, mild conditions, experimental simplicity and good yields.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.